Vaccine Development

Clinical Trials mRNA Technology mRNA Vaccines Regulatory Approval COVID-19 Vaccines Safety and Efficacy Research Funding Emergency Use Authorization Vaccine Safety Advisory Committees

FDA Panel Recommends Updating 2026–2027 COVID Shots to Target XFG Variant

The recommendation will determine which strain drives fall vaccine production.

Engineered mRNA Nanoparticles Reroute Delivery to Lymph Nodes in Mouse Study

Brazil Signs Deal for Butantan’s Single-Dose Dengue Vaccine as National Deliveries Begin

AI Pinpoints Single-Protein Mpox Target That Elicits Neutralizing Antibodies in Mice

Florida Starts Process to Drop Four School Vaccine Requirements

India Isolates Four New Omicron Sub-Variants During Latest COVID-19 Upsurge

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine

LC16m8 Vaccine Shows Strong Promise for Mpox Prevention in Latest Trials

US to Donate 1 Million Mpox Vaccine Doses to Africa

WHO Allows Early Purchase Talks for Mpox Vaccines to Expedite African Distribution

Bavarian Nordic Submits Data to Extend Mpox Vaccine Use to Adolescents

WHO Launches Initiative to Develop mRNA Vaccines for H5N1 Bird Flu